Kodiak Sciences Inc. (KOD) Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company developing therapies for retinal diseases that cause vision loss. Its antibody biopolymer conjugate platform is designed to improve drug delivery and durability in the eye. With ongoing clinical trials and strong scientific backing, Kodiak aims to create next-generation treatments for major ophthalmic conditions. […]
Read More10-year U.S. Treasury yield falling just under 4 %, which is a critical pivot point for both the stock market and the economy. Here’s what that means in simple terms: The 10-year yield represents the “price of money” for long-term borrowing—it anchors everything from mortgage rates to corporate debt costs. When yields fall, borrowing gets […]
Read More